Uvavanyo lweDigoxin

Uvavanyo lwe-digoxin lujonga ukuba ingakanani i-digoxin onayo egazini lakho. I-Digoxin luhlobo lonyango olubizwa ngokuba yi-cardiac glycoside. Isetyenziselwa ukunyanga iingxaki ezithile zentliziyo, nangona incinci kakhulu kunangaphambili.

Isampulu yegazi iyafuneka.

Buza umboneleli wakho wezempilo ukuba ufanele ukuwathatha na amayeza akho esiqhelo phambi kovavanyo.

Xa kufakwa inaliti ukutsala igazi, abanye abantu baziva iintlungu eziphakathi. Abanye baziva behlaba okanye behlaba kuphela. Emva koko, kunokubakho ukubetheka apho inaliti yafakwa khona.

Eyona njongo iphambili yolu vavanyo kukujonga eyona idosi ilungileyo ye-digoxin kunye nokuthintela iziphumo ebezingalindelekanga.

Kubalulekile ukubeka esweni inqanaba lamayeza edigitalin njenge-digoxin. Kungenxa yokuba umahluko phakathi kwenqanaba lonyango elikhuselekileyo kunye nenqanaba eliyingozi lincinci.

Ngokubanzi, amaxabiso aqhelekileyo aqala kwi-0.5 ukuya kwi-1.9 yee-nanograms nge-milliliter yegazi. Kodwa inqanaba elifanelekileyo labanye abantu linokwahluka ngokuxhomekeke kwimeko.

Imizekelo engentla yimilinganiselo eqhelekileyo yeziphumo zolu vavanyo. Amaxabiso esiqhelo ahluka kancinci phakathi kweelebhu ezahlukeneyo. Ezinye iilebhu zisebenzisa imilinganiselo eyahlukeneyo okanye ukuvavanya iisampulu ezahlukeneyo. Thetha nogqirha wakho malunga nentsingiselo yeziphumo zakho zovavanyo.

Iziphumo ezingaqhelekanga zinokuthetha ukuba ufumana okuncinci kakhulu okanye i-digoxin eninzi kakhulu.

Ixabiso eliphezulu kakhulu linokuthetha ukuba unayo okanye kunokwenzeka ukuba uphuhle i-digoxin overdose (ityhefu).

Iingozi ezinxulumene nokutsalwa kwegazi zincinci kodwa zinokubandakanya:

• Ukopha kakhulu
• Ukufa isiqaqa okanye ukuziva ungenantloko
• I-Hematoma (igazi eliqokelela phantsi kwesikhumba)
• Usulelo (umngcipheko omncinci nangaliphi na ixesha ulusu lwaphukile)

Ukungaphumeleli kwentliziyo-uvavanyo lwe-digoxin

• Uvavanyo lwegazi

UAronons JK. Glycosides zentliziyo. Ku: Aronson JK, ed. Iziphumo ebezingalindelekanga zikaMeyler zeziyobisi. Ngomhla we-16. I-Waltham, MA: Elsevier BV ;; Ngo-2016: 117-157.

I-Koch R, iLanga C, i-Minns A, i-Clark RF. Libanda, iziyobisi cardiotoxic. Ku: I-Brown DL, ed. Unonophelo olunzulu lweCardiac. Ngomhla wesi-3. IPhiladelphia, PA: Elsevier; I-2019: isahluko 34.

IMan DL. Ulawulo lwezigulana ezingaphumeleli kwintliziyo ezinamaqhekeza ancitshisiweyo. Ku: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, ii-eds. Isifo sentliziyo seBraunwald: Incwadi yesifundo seMpilo yeNtliziyo. Ngomhla we-11. IPhiladelphia, PA: Elsevier; I-2019: isahluko 25.